Specify a stock or a cryptocurrency in the search bar to get a summary
Lumos Diagnostics Holdings Ltd
LDXLumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States and Australia. Its products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also offers disposable, Lumos Leelu, and hand-held readers. The company was incorporated in 2018 and is based in Carlsbad, California. Address: 2724 Loker Ave West, Carlsbad, CA, United States, 92010
Analytics
WallStreet Target Price
0.091 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures LDX
Dividend Analytics LDX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LDX
Stock Valuation LDX
Financials LDX
Results | 2019 | Dynamics |